American Journal of Cardiology
Volume 104, Issue 4 , Pages 475-479 , 15 August 2009

Relation Between Myocardial Infarct Size and Ventricular Tachyarrhythmia Among Patients With Preserved Left Ventricular Ejection Fraction Following Fibrinolytic Therapy for ST-Segment Elevation Myocardial Infarction

  • Yuri B. Pride, MD

      Affiliations

    • Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • ,
  • Evan Appelbaum, MD

      Affiliations

    • Division of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • ,
  • Erin E. Lord, BA

      Affiliations

    • TIMI Study Group, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • ,
  • Sarah Sloan, MA, MS

      Affiliations

    • TIMI Study Group, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • ,
  • Christopher P. Cannon, MD

      Affiliations

    • TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
    • ,
  • Marc S. Sabatine, MD, MPH

      Affiliations

    • TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
    • ,
  • C. Michael Gibson, MS, MD

      Affiliations

    • Division of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • TIMI Study Group, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • Corresponding Author InformationCorresponding author: Tel: 617-525-6884; fax: 888-249-5261
    • ,
  • TIMI Study Group

Received 2 March 2009 ,Revised 6 April 2009 ,Accepted 6 April 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The CLARITY-TIMI 28 study was supported by a grant from Sanofi-Aventis, Paris, France, and Bristol-Myers Squibb, Princeton, New Jersey.

PII: S0002-9149(09)00906-0

doi: 10.1016/j.amjcard.2009.04.005

American Journal of Cardiology
Volume 104, Issue 4 , Pages 475-479 , 15 August 2009

Article Tools

* Image Usage & Resolution